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Arthropathies (FIHOA), quality of life evaluated by the SF12, psycholog-
ical impact of disease by the Hamilton Anxiety Depression scale (HAD),
and the number of radiologically affected joints. Statistics: mean [standard
deviation (sd)]; Kruskall test for univariate analysis of correlations and
multiple regression analysis.
Results: 101 patients were studied: 90% women (93% menopaused),
10% men, mean age 63.8 (8.7), BMI 23.4 (3.4), 63% with a familial history
of HOA, mean symptoms duration 10 (7.5) years. Aesthetic damage
scored 43.2 (37.7) mm. It was scored 11.6 (25.6) by men and 46.9 (37.2)
by women. Univariate analysis identiﬁed the following possible clinically
correlated parameters: gender (p = 0.002); the number of painful joints on
pressure (Spearman r: 0.30; p = 0.007); n. of radiologically affected joints
(r: 0.26; p = 0.01); n. of spontaneously painful joints (r: 0.23; p = 0.05);
and a trend for the n. of nodal joints (r:0.18; p = 0.08). No correlation was
found for pain at rest or on activity, FIHOA, SF12, HAD. Results of the
multivariate analysis are in the table.




N. of painful joints on pressure 4.9 (2.0) [1.0; 8.8] 0.01
Sex 31.9 (14.5) [3.5; 60.3] 0.03
N. of affected joints on X-rays 0.7 (1.3) [−1.8; 3.2] 0.60
N. of painful joints 4.2 (3.1) [−1.8;
10.3]
0.17
N. of nodal joints −1.4 (2.0) [−5.2; 2.5] 0.49
FIHOA 0.5 (0.9) [−1.2; 2.3] 0.56
HAD depression 1.2 (1.6) [−2.0; 4.3] 0.47
Conclusions: This study highlights for the ﬁrst time that aesthetic
damage is a major concern for HOA patients. Aesthetic damage was
independant from pain VAS and functional impairment but signiﬁcantly
correlated with female gender and surprisingly the number of painful joints
on pressure. Interestingly no association was found with depression.
This issue should deserve more attention and a speciﬁc tool exploring
aesthetic damage in hand OA and its dimensions should be developed.
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Purpose: Osteoarthritis (OA) of the knee causes pain and loss of joint
mobility which leads to restriction in physical functioning: patients can no
longer walk as far or fast. The purpose of this study was to compare the
isokinetic strength measurements of the quadriceps and hamstring and
functional outcomes in patients with knee osteoarthritis (OA) and healthy
subjects.
Methods: A total of 159 volunteer subjects, 60 patients (mean
age: 52.31±8.73 years) with bilateral knee OA and 99 age-matched
(50.79±7.77 years) healthy subjects participated in the study. Isokinetic
peak torque (PT) measurements of the knee extensors and ﬂexors at
180º/sec (ISOMED 2000), timed performance test (timed up&go) (TUG)
for functional capacity, and body composition analyse (TANITA) for body
weight, body mass index (BMI) and fat percent were used.
Results: The healthy subjects demonstrated greater differences in ﬂexor
isokinetic torques and TUG test results than the OA group (right knee
ﬂexor PT; t = −5.05, p = 0.0, left knee ﬂexor PT; t = −6.5, p = 0.0, TUG
test; t = 6.01, p = 0.0). Participants in both groups demonstrated similar
results and no signiﬁcance in extensor PT values of the knees (right
knee extensor PT; t = −1.05, p = 0.29, left knee extensor PT; t = −1.05,
p = 0.29). In body composition analyse healthy subjects’ body weights and
BMI found greater than the OA group (body weight: t = −2.12, p = 0.035,
BMI: t = −3.55, p = 0.001).
Conclusions: Quadriceps muscle strength and weight differences may
not be the most important indicators in the knee OA. To improve agonist-
antagonist muscle balance of the quadriceps and hamstring muscle may
be the most important than focused on only strengthening the quadriceps
muscle in rehabilitation.
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Purpose: Objectives: To look at the relationship between the number of
clinically or radiologically affected joints and clinical parameters in HOA.
Methods: Prospective cross-sectional study. Successive outpatients visit-
ing at the Hand OA clinic of St-Antoine hospital were examined according
to a standardized case report form. Postero-anterior X-rays of both
hands on a single ﬁlm were performed. Data collected: demographics,
personal/familial medical history, HOA history, clinical and radiological
description, including nodes, pain at rest and on move (VAS), pain on
joint pressure, patient’s global disease assessment, aesthetic damage
scored by patients on a 0–100mm VAS, function (Functional Index for
Hand Arthropathies (FIHOA)), quality of life (SF12), psychological impact
of HOA (Hamilton Anxiety Depression (HAD) scale) and the number of
affected joints on X-rays. Statistics: %, mean [standard deviation (sd)];
Spearman correlation coefﬁcient was used to assess correlations.
Results: 101 patients were studied: 90% women (93% on menopause),
10% men, mean age 63.8 (8.7), BMI 23.4 (3.4), 63% with a familial
history of HOA, mean symptoms duration 10 (7.5) years. Mean scores
were 48.3 (25.4) mm for pain during activity, 43.2 (37.7) mm for aesthetic
damage, 41.4 (27.7) mm for patients global assessment, 8.2 (6.0) for
FIHOA [0−30], 6.6 (3.3) for HAD scale [0−21], 44.7 (7.2) for SF12 [0–
100].
Results of the correlations between the numbers of affected joints and
clinical outcomes are in the table.
Table. Correlations between the number of HOA joints affected and clinical outcomes
Variable r; P N of spontaneous
painful joints
N of painful joints
on pressure
N nodal joints N radiologically
affected joints
Pain at rest 0.07; 0.53 0.22; 0.06 0.01; 0.90 0.05; 0.63
Pain on activity 0.05; 0.66 0.33; 0.003 0.05; 0.60 0.22; 0.04
Aesthetic damage 0.23; 0.05 0.30; 0.007 0.18; 0.08 0.26; 0.01
Patients global −0.03; 0.80 0.38; 0.001 −0.07; 0.52 0.18; 0.09
FIHOA 0.17; 0.16 0.30; 0.01 0.04; 0.72 0.17; 0.11
SF12 MCS 0.04; 0.77 −0.14; 0.22 0.02; 0.83 0.06; 0.59
SF12 PCS −0.17; 0.17 −0.28; 0.02 0.03; 0.79 −0.13; 0.25
SF12 total −0.09; 0.46 −0.23; 0.05 0.008; 0.93 −0.06; 0.58
HAD depression −0.08; 0.50 0.13; 0.28 0.03; 0.78 0.08; 0.44
HAD anxiety 0.11; 0.34 0.21; 0.07 0.08; 0.43 0.15; 0.16
HAD total 0.01; 0.93 0.17; 0.13 0.05; 0.61 0.13; 0.21
In addition, no correlation between night awakening and the number of
affected joints was observed. Conversely, morning stiffness was signif-
icantly correlated to the number of painful joints (p = 0.05), the number
of nodal joints (p = 0.01) and the number of affected joints on X-rays
(p 0.006).
Conclusions: The number of radiologically affected joints is correlated
to pain on activity, aesthetic damage and morning stiffness in HOA
patients. Moreover, the number of painful joints on pressure is signiﬁcantly
associated with a higher score of all clinical parameters but morning
stiffness.
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Purpose: The purpose of this study was to determine patients’ expecta-
tion of treatment and document outcomes following treatment protocol in
which corticosteroid is used, in addition to initial Synvisc injection 3 series.
Methods: 63 patients were enrolled in a prospective cohort study, IRB
approved with informed patient consent. Inclusion criteria were patients
aged 18−80 years with knee osteoarthritis diagnosis based on radio-
graphic examination (Kellgren-Lawrence). Patients with prior synovec-
tomy on injection knee were excluded, as well as if they had rheuma-
toid disease, any serious systemic disease, acute synovitis, excessive
effusion, allergy to avian products/hyaluronan-based injection compo-
nents/corticosteroid injection, pregnant, previous arthroscopic surgery
within last 6 months or joint infection within previous 3 months. Patients
were given standard course of 3 (2ml) weekly injections. At ﬁrst injection,
in addition to Hylan G-F 20, corticosteroid was added, but not in second
and third. At 3, 6 and 12 weeks and 6 months following injection series
completion, patients completed a form with WOMAC score. Patients
